TEL AVIV, Israel, Jan. 25, 2021 (GLOBE NEWSWIRE) Bioblast Pharma Ltd. (Nasdaq:ORPN), reports to have launched the production of sildenafil citrate marketed under the name of generic Viagra. The company is committed to help diversify...
The post Bioblast Pharma to Launch Generic Viagra first appeared on http://rotationmedical.com.